BioSpace News Archive

eClinicalWorks®, a leader in healthcare IT solutions, today announced the successful implementation of its Vaccine Administration Management Solution (VAMS), which is supporting the administration of COVID-19 vaccine doses across 29 states.

The International Gaucher Alliance (IGA) and Kantar Health announce today the launch of the disease registry GARDIAN: Gaucher Registry for Development Innovation and Analysis of Neuronopathic Disease.

Aquavit Holdings LLC announced today that it acquired an exclusive license to register, market and commercialize a botulinum toxin (DTX-021) in the United States and Canada.

The overdose crisis continues to affect communities and families across Canada. Tragically, we have seen significant increases in overdose deaths and related harms during the COVID-19 pandemic, including in Toronto where overdoses deaths increased significantly between January 1 and November 30 last year.

Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Trodelvy® (sacituzumab govitecan-hziy) to Gilead Sciences, Inc. (Nasdaq: GILD),

TriSalus Life Sciences®, an emerging immuno-oncology company committed to transforming outcomes for patients with liver and pancreatic tumors, today announced data presented at the American Association of Cancer Research showing that regional delivery of oligodeoxynucleotide 2395 (ODN2395) activated the toll-like receptor 9 (TLR9), resulting in reduced tumor burden of liver metastases in mice.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that Brilacidin, the Company’s defensin-mimetic drug candidate, was featured in the “Mason Science Series: Rising to the National and International COVID-19 Challenge,” a presentation of George Mason University.

The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular heartbeats

Today, AMRA Medical announced an expansion of its dataset, resulting from a collaboration with Pfizer Inc. and UK Biobank, from 10,000 to 25,000 UK Biobank participants – another step toward their shared goal of analyzing the body composition of 100,000 individuals

Today, three leading synthetic biology companies announced the launch of the Synthetic Biology (SynBio) Coalition (www.synbioco.com) to promote investment and support for the American synthetic biology industry. Synthetic biology is a field of science that involves redesigning microorganisms for useful purposes.